Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-06-18

The European Advanced Translational Research Infrastructure in Medicine

Objective

Efficient translation of research discoveries into industrial application is an essential element to maintain Europe’s competitiveness in the biomedical and health industry. The main bottleneck is the lack and the fragmented nature of essential research infrastructure and know-how, leading to unacceptable delays and/or preventing the development of new innovative medicines. The aim of EATRIS is to fill this gap by developing a European Advanced Translation Research InfraStructure consisting of key preclinical and clinical components necessary to support the development of new diagnostic or therapeutic strategies at all stages of the biomedical R&D-process. EATRIS will operate through a network of biomedical translation research centres across Europe which will provide user access to: • State of the art animal facilities for preclinical proof of principle and proof of concept studies • Small molecule screening facilities to identify and characterize new drug targets • High-resolution imaging facilities for preclinical and clinical validation • Disease-specific patient and population cohorts to develop and validate new innovative diagnostic and therapeutic strategies • Centralized GMP facilities for bioprocess development and manufacturing • Facilities for Clinical Phase I studies. During the preparatory phase EATRIS will work out a master plan describing in detail the establishment and mode of operation of the planned pan-European infrastructure during a later construction phase: This will include an agreement on the key legal, governance, strategic and financial issues as well as a concept to train and educate the next generation of biomedical translation researchers. Users of EATRIS will be biomedical researchers and clinical scientists located at universities, research institutions or SME´s that need to use this infrastructure in order to overcome specific bottlenecks and to move their research projects from a discovery to a preclinical and clinical stage.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

FP7-INFRASTRUCTURES-2007-1
See other projects for this call

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

CP-CSA-Infra - Combination of CP and CSA

Coordinator

HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH
EU contribution
€ 1 758 208,00
Address
INHOFFENSTRASSE 7
38124 Braunschweig
Germany

See on map

Region
Niedersachsen Braunschweig Braunschweig, Kreisfreie Stadt
Activity type
Research Organisations
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (19)

My booklet 0 0